<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">
hero-press-releases-1

Newsroom

News

External stories on biodesix

Posts in: Genestrat liquid biopsy

CAP Today: Revived Hopes, Fresh Challenges with Liquid Biopsy

Article in CAP Today about liquid biopsy and the opportunity that tests like Biodesix's Genestrat offer to lung cancer treatment

Biodesix Launches GeneStrat Targeted Liquid Biopsy Mutation Test for Patients with Advanced Lung Cancer

Genestrat: a targeted liquid biopsy for patients with NSCLC. Blood test with 72 hour turnaround time.